Epigenomics (EPGNY) Short Interest Ratio & Short Volume $2.39 0.00 (0.00%) (As of 04/6/2023) Add Compare Share Share Short Interest Stock Analysis Epigenomics Short Interest DataEpigenomics (EPGNY) has a short interest of 100 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 1.0, indicating that it would take 1.0 days of the average trading volume of 100 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest100 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$239.00Short Interest Ratio1.0 Days to CoverLast Record DateMarch 31, 2023Today's Trading Volume0 sharesAverage Trading Volume100 sharesToday's Volume Vs. Average0% Short Selling Epigenomics? Sign up to receive the latest short interest report for Epigenomics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEPGNY Short Interest Over TimeEPGNY Days to Cover Over TimeEPGNY Percentage of Float Shorted Over Time Ad Brownstone ResearchBill Gates’ Next Big Thing: “Exegesis AI”In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.I believe we are about to do it again with this new AI project called Stargate Epigenomics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2023100 shares $239.00 No ChangeN/A1 $2.39 3/15/2023100 shares $239.00 No ChangeN/A1 $2.39 2/28/2023100 shares $239.00 No ChangeN/A1 $2.39 2/15/2023100 shares $239.00 No ChangeN/A0 $2.39 1/31/2023100 shares $239.00 No ChangeN/A1 $2.39 12/15/2022200 shares $478.00 No ChangeN/A0 $2.39 Get the Latest News and Ratings for EPGNY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Epigenomics and its competitors with MarketBeat's FREE daily newsletter. 11/30/2022200 shares $478.00 No ChangeN/A0 $2.39 11/15/2022200 shares $478.00 No ChangeN/A0 $2.39 10/31/2022200 shares $478.00 No ChangeN/A0 $2.39 10/15/2022200 shares $478.00 No ChangeN/A0 $2.39 9/30/2022200 shares $478.00 +100.0%N/A2 $2.39 9/15/2022100 shares $280.00 No ChangeN/A1 $2.80 8/31/2022100 shares $280.00 No ChangeN/A1 $2.80 8/15/2022100 shares $280.00 No ChangeN/A1 $2.80 7/31/2022100 shares $280.00 No ChangeN/A0 $2.80 7/15/2022100 shares $280.00 No ChangeN/A1 $2.80 6/30/2022100 shares $280.00 No ChangeN/A0 $2.80 6/15/2022100 shares $280.00 No ChangeN/A0 $2.80 5/31/2022100 shares $280.00 No ChangeN/A1 $2.80 5/15/2022100 shares $280.00 No ChangeN/A0 $2.80 4/30/2022100 shares $280.00 No ChangeN/A1 $2.80 4/15/2022100 shares $280.00 No ChangeN/A0 $2.80 3/31/2022100 shares $280.00 No ChangeN/A1 $2.80 3/15/2022100 shares $280.00 No ChangeN/A1 $2.80 2/28/2022100 shares $293.00 No ChangeN/A1 $2.93 2/15/2022100 shares $293.00 No ChangeN/A1 $2.93 1/31/2022100 shares $356.99 No ChangeN/A1 $3.57 1/15/2022100 shares $356.99 No ChangeN/A1 $3.57 12/31/2021100 shares $354.00 No ChangeN/A0.3 $3.54 12/15/2021100 shares $439.00 No ChangeN/A1 $4.39 11/30/2021100 shares $439.00 No ChangeN/A1 $4.39 9/15/20211,000 shares $14,370.00 +150.0%N/A2.5 $14.37 8/31/2021400 shares $3,120.00 No ChangeN/A4 $7.80 8/13/2021400 shares $3,120.00 No ChangeN/A0 $7.80 7/30/2021400 shares $3,120.00 No ChangeN/A0 $7.80 7/15/2021400 shares $3,120.00 No ChangeN/A4 $7.80 6/30/2021400 shares $3,120.00 +33.3%N/A0 $7.80 6/15/2021300 shares $2,340.00 No ChangeN/A3 $7.80 5/28/2021300 shares $2,340.00 No ChangeN/A3 $7.80 5/14/2021300 shares $2,340.00 -40.0%N/A3 $7.80⭕ [URGENT] Buy Alert just triggered (Ad)My absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> 4/30/2021500 shares $4,120.00 +66.7%N/A5 $8.24 4/15/2021300 shares $4,131.00 No ChangeN/A3 $13.77 3/31/2021300 shares $4,131.00 +200.0%N/A3 $13.77 3/15/2021100 shares $1,360.00 No ChangeN/A1 $13.60 2/26/2021100 shares $1,605.00 No ChangeN/A1 $16.05 2/12/2021100 shares $1,548.00 No ChangeN/A1 $15.48 1/29/2021100 shares $2,054.00 No ChangeN/A1 $20.54 1/15/2021400 shares $13,200.00 No ChangeN/A0.8 $33.00 12/31/2020400 shares $13,200.00 -76.5%N/A0.8 $33.00 12/15/2020400 shares $7,266.00 -76.5%N/A0.8 $18.17 11/30/20201,700 shares $4,539.00 +6.3%N/A17 $2.67 11/15/20201,600 shares $4,272.00 -23.8%N/A16 $2.67 10/30/20202,100 shares $6,825.00 -4.6%N/A0.9 $3.25 10/15/20202,200 shares $31,900.00 +10.0%N/A7.3 $14.50 9/30/20202,000 shares $28,760.00 +1,900.0%N/A3.3 $14.38 9/15/2020100 shares $1,585.00 -50.0%N/A1 $15.85 8/31/2020200 shares $3,664.00 +100.0%N/A0.3 $18.32 8/14/2020100 shares $1,559.00 No ChangeN/A1 $15.59 7/31/2020100 shares $1,319.00 No ChangeN/A0.3 $13.19 7/15/2020100 shares $1,249.00 No ChangeN/A0 $12.49 6/30/2020100 shares $750.00 No ChangeN/A0.5 $7.50 6/15/2020100 shares $597.00 No ChangeN/A1 $5.97 5/29/2020100 shares $597.00 No ChangeN/A0 $5.97 5/15/2020100 shares $597.00 No ChangeN/A1 $5.97 4/30/2020100 shares $780.00 No ChangeN/A1 $7.80 4/15/2020100 shares $755.00 No ChangeN/A0 $7.55 3/31/2020100 shares $755.00 No ChangeN/A0 $7.55 3/13/2020100 shares $755.00 No ChangeN/A0.1 $7.55 2/28/2020100 shares $755.00 No ChangeN/A0 $7.55 2/14/2020100 shares $755.00 No ChangeN/A0 $7.55 1/31/2020100 shares $755.00 No ChangeN/A0 $7.55 EPGNY Short Interest - Frequently Asked Questions What is Epigenomics' current short interest? Short interest is the volume of Epigenomics shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 100 shares of EPGNY short. Learn More on Epigenomics' current short interest. What is a good short interest ratio for Epigenomics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EPGNY shares currently have a short interest ratio of 1.0. Learn More on Epigenomics's short interest ratio. How does Epigenomics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Epigenomics: Agilent Technologies, Inc. (1.10%), VolitionRx Limited (0.71%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.66 billion), TC Energy Co. ($4.13 billion), Occidental Petroleum Co. ($3.04 billion), Moderna, Inc. ($2.63 billion), Coinbase Global, Inc. ($2.51 billion), T. Rowe Price Group, Inc. ($2.29 billion), Paramount Global ($2.26 billion), Verisk Analytics, Inc. ($2.19 billion), Etsy, Inc. ($1.84 billion), and Voya Financial, Inc. ($1.67 billion). View all of the most shorted stocks. What does it mean to sell short Epigenomics stock? Short selling EPGNY is an investing strategy that aims to generate trading profit from Epigenomics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Epigenomics? A short squeeze for Epigenomics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EPGNY, which in turn drives the price of the stock up even further. How often is Epigenomics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EPGNY, twice per month. The most recent reporting period available is March, 31 2023. More Short Interest Resources from MarketBeat Related Companies: ANPCY Short Squeeze BIAFW Short Squeeze ITGDF Short Squeeze IDGXF Short Squeeze IZOZF Short Squeeze PRENW Short Squeeze RSHN Short Squeeze SBLOF Short Squeeze SKHCF Short Squeeze SQIDF Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:EPGNY) was last updated on 9/17/2024 by MarketBeat.com Staff From Our PartnersAI Detects Profit Surge On MondayThis has given investors the opportunity to beat the market by 1,700% and a 100% win rate to begin the year.Monument Traders Alliance | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredIntroducing the PerceptronOn Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. Th...Brownstone Research | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredFortune: Nexus Technology has “ignited a gold rush”Business Insider estimates it could grow 8,966% in the near future... And Goldman Sachs says it could grow ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Epigenomics AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Epigenomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.